Variables | Asthmatic patients (n = 448) | Non-asthmatic controls (n = 448) | p-value |
---|---|---|---|
Age, years (Mean ± SD) | 34.4 ± 18.2 | 36.7 ± 18.6 | 0.06 |
Gender, female, n (%) | 256 (57.1) | 249 (55.6) | 0.6 |
Soluble BAFF levels [pg/ml]a | 768 (554.2–999.1) | 804.3 (628.5–964.3) | 0.16b |
mRNA levels BAFF1c (Mean ± SD) | 3.21 ± 1.39 | 3.12 ± 1.14 | 0.6d |
mRNA levels BAFF2c (Mean ± SD) | 2.79 ± 1.04 | 2.70 ± 0.94 | 0.5d |
Total IgE, UI/mla,e | 699.7 (236.3–1065.8) | 148.8 (58.3–408.1) | <0.001b |
Ig levels to parasite (OD) a,e | Â | Â | Â |
sIgE to Ascaris | 0.117 (0.100–0.150) | 0.105 (0.091–0.134) | <0.001b |
sIgG to Ascaris | 1.99 (1.60–2.34) | 2.17 (1.73–2.69) | <0.001b |
sIgE to ABA-1 | 0.125 (0.098–0.187) | 0.119 (0.099–0.154) | 0.18b |
sIgG to ABA-1 | 1.49 (1.09–1.83) | 1.70 (1.36–2.11) | <0.001b |
Ig levels to HDM (OD) a,e | Â | Â | Â |
IgE to D. pteronyssinus | 0.191 (0.115–0.520) | 0.099 (0.089–0.122) | <0.001b |
IgE to B. tropicalis | 0.231 (0.110–1.06) | 0.098 (0.089–0.122) | <0.001b |